TV News LIES

Friday, Oct 24th

Last update05:59:50 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Doctor tests positive for Ebola at New York hospital

NY doctor tests positive for ebolaA physician who recently returned to New York from Ebola-ravaged west Africa has tested positive for...

US forces Ebola-risk passengers to land at 'enhanced screening' airports

Full screening airportThe United States has unveiled new Ebola-related travel restrictions on visitors from West Africa, forcing passengers...

Thousands of U.S. children are improperly medicated each year

Children wrongly medicated in USEvery eight minutes, a child in the United States is improperly medicated at home -- that...

Paralyzed man walks again after cell transplant

paralyzed man walks againA paralysed man has been able to walk again after a pioneering therapy that involved transplanting...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!